Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Other Accumulated Expenses (2016 - 2020)

AC Immune has reported Other Accumulated Expenses over the past 5 years, most recently at $130264.7 for Q1 2020.

  • Quarterly Other Accumulated Expenses changed N/A to $130264.7 in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $130264.7 through Mar 2020, changed N/A year-over-year, with the annual reading at $1.1 million for FY2018, 145.68% up from the prior year.
  • Other Accumulated Expenses was $130264.7 for Q1 2020 at AC Immune, down from $1.1 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $1.5 million in Q3 2017 and troughed at -$709484.1 in Q2 2017.
  • The 4-year median for Other Accumulated Expenses is $372276.4 (2017), against an average of $405995.3.
  • Year-over-year, Other Accumulated Expenses crashed 353.09% in 2017 and then surged 145.68% in 2018.
  • A 4-year view of Other Accumulated Expenses shows it stood at $817020.0 in 2016, then crashed by 43.18% to $464219.3 in 2017, then soared by 145.68% to $1.1 million in 2018, then plummeted by 88.58% to $130264.7 in 2020.
  • Per Business Quant, the three most recent readings for ACIU's Other Accumulated Expenses are $130264.7 (Q1 2020), $1.1 million (Q4 2018), and $464219.3 (Q4 2017).